DNAPrint Genomics Stock Forecast - Double Exponential Smoothing
The Double Exponential Smoothing forecasted value of DNAPrint Genomics on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00 and the sum of the absolute errors of 0.00. DNAPrint Stock Forecast is based on your current time horizon. We recommend always using this module together with an analysis of DNAPrint Genomics' historical fundamentals, such as revenue growth or operating cash flow patterns.
DNAPrint Genomics Double Exponential Smoothing Price Forecast For the 1st of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of DNAPrint Genomics on the next trading day is expected to be 0.00 with a mean absolute deviation of 0.00, mean absolute percentage error of 0.00, and the sum of the absolute errors of 0.00.Please note that although there have been many attempts to predict DNAPrint Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that DNAPrint Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
DNAPrint Genomics Stock Forecast Pattern
| Backtest DNAPrint Genomics | DNAPrint Genomics Price Prediction | Buy or Sell Advice |
DNAPrint Genomics Forecasted Value
In the context of forecasting DNAPrint Genomics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. DNAPrint Genomics' downside and upside margins for the forecasting period are 0.00 and 125.99, respectively. We have considered DNAPrint Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of DNAPrint Genomics stock data series using in forecasting. Note that when a statistical model is used to represent DNAPrint Genomics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0 |
| MAPE | Mean absolute percentage error | 0.0 |
| SAE | Sum of the absolute errors | 0.0 |
Predictive Modules for DNAPrint Genomics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as DNAPrint Genomics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for DNAPrint Genomics
For every potential investor in DNAPrint, whether a beginner or expert, DNAPrint Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. DNAPrint Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in DNAPrint. Basic forecasting techniques help filter out the noise by identifying DNAPrint Genomics' price trends.DNAPrint Genomics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DNAPrint Genomics stock to make a market-neutral strategy. Peer analysis of DNAPrint Genomics could also be used in its relative valuation, which is a method of valuing DNAPrint Genomics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
DNAPrint Genomics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of DNAPrint Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of DNAPrint Genomics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
DNAPrint Genomics Risk Indicators
The analysis of DNAPrint Genomics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in DNAPrint Genomics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dnaprint stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 31.24 | |||
| Standard Deviation | 125.99 | |||
| Variance | 15873.02 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Historical Fundamental Analysis of DNAPrint Genomics to cross-verify your projections. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DNAPrint Genomics. If investors know DNAPrint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DNAPrint Genomics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of DNAPrint Genomics is measured differently than its book value, which is the value of DNAPrint that is recorded on the company's balance sheet. Investors also form their own opinion of DNAPrint Genomics' value that differs from its market value or its book value, called intrinsic value, which is DNAPrint Genomics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DNAPrint Genomics' market value can be influenced by many factors that don't directly affect DNAPrint Genomics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DNAPrint Genomics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DNAPrint Genomics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DNAPrint Genomics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.